Morphometric analysis of treatment effects of the Balters bionator in growing Class II patients

Objective: To investigate the effects of the standard (Class II) Balters bionator in growing patients with Class II malocclusion with mandibular retrusion by using morphometrics (thin-plate spline [TPS] analysis). Materials and Methods: Thirty-one Class II patients (17 male and 14 female) were treated with the Balters bionator (bionator group). Mean age at the start of treatment (T0) was 10.3 years, while it was 13 years at the end of treatment (T1). Mean treatment time was 2 years and 2 months. The control group consisted of 22 subjects (14 male and 8 female) with untreated Class II malocclusion. Mean age at T0 was 10.2 years, while it was 12.2 years at T1. The observation period lasted 2 years on average. TPS analysis evaluated statistical (permutation tests) differences in the craniofacial shape and size between the bionator and control groups. Results: Through TPS analysis (deformation grids) the bionator group showed significant shape changes in the mandible that could be described as a mandibular forward and downward displacement. The control group showed no statistically significant differences in the correction of Class II malocclusion. Conclusions: Bionator appliance is able to induce significant mandibular shape changes that lead to the correction of Class II dentoskeletal disharmony. © 2013 by The EH Angle Education and Research Foundation, Inc.

Nível de atividade física, comorbidades e idade de pacientes hipertensos

Physical inactivity is associated with chronic diseases in older adults. There are different domains of physical activity, such as leisure and locomotion. This study investigate the associations between different domains of physical activity, comorbidities and aging in hypertensive adults. Participants included 192 hypertensive respondents classified in groups of active and insufficiently active for leisure-time, locomotion, occupation and total time. They were stratified in age groups. Waist circumference was measured and comorbidities were self-reported. The chi-square test analyzed these associations; a one-way ANOVA compared the age groups (significance at p <0.05). The mean total time and occupational physical activity were lower for groups ages over 60 and 70 years, respectively. Occupational activity was associated with age in the female group, and with cholesterol and diabetes in males, who also had physical activity of locomotion associated with waist circumference. Physical activity of hypertensive patients is associated with comorbidities in different age groups and sex.

Effects of magnesium sulphate on the pharmacodynamics of rocuronium in patients aged 60 years and older: A randomised trial

BACKGROUND There is little information on the interaction between magnesium sulphate (MgSO4) and rocuronium in elderly patients. With a growing number of older patients who need surgical procedures, it is increasingly important to study this age group. OBJECTIVE To evaluate the effects of MgSO4 administration on the pharmacodynamics of rocuronium in patients aged 60 years or older. DESIGN A randomised controlled trial. SETTING A tertiary care hospital. PATIENTS Sixty-four patients, aged 60 years or older, American Society of Anesthesiologists (ASA) physical status classes I to III, scheduled for elective oncological head and neck surgery. Exclusion criteria were severe renal insufficiency (calculated creatinine clearance <30 ml min-1), preoperatorive serum magnesium concentration of more than 1.25 mmol l1 and patients receiving drugs known to affect neuromuscular function. INTERVENTIONS Patients were randomly allocated to one of two groups: in the magnesium group, patients received MgSO4 30mgkg1 intravenously, for 10 min, and then a continuous intravenous infusion at a rate of 1 g h-1. The control group received the same volume of physiological saline. Neuromuscular function was evaluated continuously in both groups. MAIN OUTCOME MEASURES Total recovery time was the primary outcome. Onset time, clinical duration, recovery index and recovery time were considered as secondary endpoints. Values are given as mean [SD]. RESULTS Total recovery time from neuromuscular block (NMB) was 113 [36] min in the magnesium group and 101 [39] min in the control group. Clinical duration was 69 [23] min in the magnesium group and 59 [28] min in the control group. Recovery index was 19 [36] min in the magnesium group and 17 [6] min in the control group. Recovery timewas 44 [22] min in the magnesium group and 42 [18] min in the control group. There were no statistically significant differences between the groups in any of the recovery indices. In the magnesium group, the mean onset time was 144 [58] s, significantly shorter than the onset time in the group that received physiological saline, which was 187 [90] s (P-0.03). Group variances were compared using an F test: onset time varied significantly less in the magnesium group (P-0.02). CONCLUSION In oncology patients of 60 or more years of age, preadministration of MgSO4, with the doses used in this study, significantly reduced the onset time of NMB induced by rocuronium. © 2013 European Society of Anaesthesiology.

Efeito do exercício prévio sobre os parâmetros da cinética do VO2 durante o exercício moderado em ciclistas e indivíduos sedentários

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Análise químico-farmacêutica de cloridrato de ciprofloxacino em solução oftálmica

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Estabelecimento e superação de dormência em sementes de Erythrina speciosa Andrews

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Comprometimento cognitivo e qualidade de vida de pacientes com insuficiência renal crônica avançada

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Produção de mudas de Dypsis decaryi (Jum.) Beentje & J. Dransf: efeito de tratamentos pré-germinativos e de substratos

Pós-graduação em Agronomia - FEIS

Análise químico-farmacêutica e estudo de estabilidade de cefuroxima sódica injetável

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Estudo farmacocinético e farmacodinâmico de cloridrato metadona por via oral, intramuscular e intravenosa e carreadores lipídicos nanoparticulados de metadona via oral em equinos

Pós-graduação em Anestesiologia - FMB

Aspiração folicular videolaparoscópica em ovelhas recém-desmamadas submetidas à estimulação ovariana

Pós-graduação em Medicina Veterinária - FCAV

Estudo comparativo das associações de macroinvertebrados bentônicos e do sedimento dos reservatórios de Chavantes e Salto Grande (rio Paranapanema, SP, PR) e avaliação toxicológica da água e sedimento

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Efeito do exercício prévio no ciclismo de curta duração

INTRODUÇÃO:O exercício prévio tem importantes implicações na preparação de atletas antes de competições.OBJETIVO:Analisar o efeito de um exercício prévio realizado no domínio pesado no pico de torque (PTORQUE) medido após exercício severo.MÉTODOS:Participaram deste estudo 14 homens ativos (idade: 26 ± 4 anos, VO2max: 44 ± 6 mLO2.min-1.kg-1) que realizaram sete testes em dias diferentes: a) teste progressivo de rampa para determinação do VO2max e da potência pico; b) quatro testes de carga constante para determinação da potência crítica, capacidade de trabalho anaeróbio e potência correspondente ao tempo de exaustão de 3 min (PTLim3min) e; c) dois testes de carga constante de 2 min na PTLim3min seguidos por um sprint all out de 10 s, a fim de medir o PTORQUE. Este último protocolo foi realizado com (EP) e sem (CON) a realização de um exercício prévio pesado.RESULTADOS:O PTORQUE foi significantemente maior após o EP (101 ± 30 Nm) em relação à condição CON (95 ± 23 Nm). O tempo da resposta médio (TRM) do VO2 foi significantemente menor após o EP (24 ± 7 s) em relação à condição CON (32 ± 10 s). A amplitude primária do VO2 aumentou significantemente após o EP (2598 ± 421 mLO2.min-1) em relação à condição CON (2184 ± 246 mLO2.min-1). O déficit de O2 foi significantemente menor após o exercício prévio (980 ± 432 mLO2) em relação à condição CON (1273 ± 398 mLO2). Houve correlação significante entre a variação do déficit de O2 com a do PTORQUE (r = 0,53) e da variação do TRM com a do PTORQUE (r = 0,53).CONCLUSÃO:Pode-se concluir que o PTORQUE é maior após exercício aeróbio de curta duração precedido do EP. Deste modo, esta estratégia pode ser interessante como preparação para algumas competições esportivas.

The Positive Effects of Priming Exercise on Oxygen Uptake Kinetics and High-Intensity Exercise Performance Are Not Magnified by a Fast-Start Pacing Strategy in Trained Cyclists

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Analysis of rocuronium in human plasma by liquid chromatography-tandem mass spectrometry with application in clinical pharmacokinetics

Rocuronium (ROC) is a neuromuscular blocking agent used in surgical procedures which is eliminated primarily by biliary excretion. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for analysis of ROC in human plasma. Separation of ROC and IS (verapamil) was performed using an endcapped C-18 column and a mixture of water:acetonitrile:trifluoracetic acid (50:50:0.1, v/v) as mobile phase. Aliquots of 100 mu L of human plasma were extracted at pH 3, using dichloromethane. The lower limit of quantification of 5 ng/mL shows the high sensitivity of this method. Intra- and inter-assay precision (as relative standard deviation) was all <= 14.2% and accuracy (as relative standard error) did not exceed 10.1%. The validated method was successfully applied to quantify ROC concentrations in patients under surgical procedures up to 6 h after the administration of the 0.4-0.9 mg/kg ROC. The pharmacokinetic parameter estimations of ROC showed AUC/dose of 563 mu g min/mL, total clearance of 2.5 mL/min/kg, volume of distribution at steady state of 190 mL/kg and mean residence time of 83 min. (C) 2013 Elsevier B.V. All rights reserved.